Endovascular Therapy for Acute Ischemic Stroke Trial

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 225 participants.

Also called NCT02350283

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 225 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02350283
Other papers using this trial's data
  • Mechanical thrombectomy and rescue therapy for intracranial large artery occlusion with underlying atherosclerosis Journal of neurointerventional surgery, 2018-08 DOI, PubMed 29203731

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02350283. Non-randomized; no masking; primary purpose treatment. Start 2015-01 (actual); primary completion 2015-07 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Endovascular Therapy for Acute Ischemic Stroke Trial
Acronym
EAST
Intervention (Device)
Interventional treatment with Solitaire
Lead sponsor
Ministry of Science and Technology of the People´s Republic of China (class: other government)

Record details

Record id
cardio:ct-nct02350283
Content hash
d05b822e5873011142b4c5b3bbe7331fb5f958e6beca61f7ec208e74407ba6b8